MX361058B - Método para detectar células tumorales circulantes 5t4-positivas y métodos de diagnóstico de cáncer 5t4-positivo en un sujeto mamífero. - Google Patents
Método para detectar células tumorales circulantes 5t4-positivas y métodos de diagnóstico de cáncer 5t4-positivo en un sujeto mamífero.Info
- Publication number
- MX361058B MX361058B MX2014008928A MX2014008928A MX361058B MX 361058 B MX361058 B MX 361058B MX 2014008928 A MX2014008928 A MX 2014008928A MX 2014008928 A MX2014008928 A MX 2014008928A MX 361058 B MX361058 B MX 361058B
- Authority
- MX
- Mexico
- Prior art keywords
- positive
- detecting
- tumor cells
- circulating tumor
- diagnostic methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G01N33/575—
-
- G01N33/5758—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70589—CD45
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261590066P | 2012-01-24 | 2012-01-24 | |
| US201361753665P | 2013-01-17 | 2013-01-17 | |
| PCT/IB2013/050547 WO2013111054A1 (en) | 2012-01-24 | 2013-01-22 | Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014008928A MX2014008928A (es) | 2014-10-24 |
| MX361058B true MX361058B (es) | 2018-11-23 |
Family
ID=47844410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014008928A MX361058B (es) | 2012-01-24 | 2013-01-22 | Método para detectar células tumorales circulantes 5t4-positivas y métodos de diagnóstico de cáncer 5t4-positivo en un sujeto mamífero. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10254286B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2807485B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6254951B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101716555B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104094116B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2013213301A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014018192A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2861437C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2724232T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL233543B (cg-RX-API-DMAC7.html) |
| IN (1) | IN2014DN07019A (cg-RX-API-DMAC7.html) |
| MX (1) | MX361058B (cg-RX-API-DMAC7.html) |
| RU (1) | RU2646498C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013111054A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2803804B2 (ja) | 1992-08-21 | 1998-09-24 | 株式会社長澤製作所 | ボタン錠 |
| CA2778328C (en) | 2009-10-21 | 2018-12-18 | The Scripps Research Institute | Method of using non-rare cells to detect rare cells |
| US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
| US20150185204A1 (en) * | 2013-12-30 | 2015-07-02 | The Scripps Research Institute | Circulating tumor cell diagnostics for lung cancer |
| EP3100047B1 (en) | 2014-01-27 | 2021-08-11 | Epic Sciences, Inc. | Circulating tumor cell diagnostics for prostate cancer biomarkers |
| US10545151B2 (en) * | 2014-02-21 | 2020-01-28 | Epic Sciences, Inc. | Methods for analyzing rare circulating cells |
| WO2015155345A1 (en) * | 2014-04-11 | 2015-10-15 | Medimmune Limited | Antibodies and antibody-drug conjugates |
| EA201692223A1 (ru) * | 2014-05-09 | 2017-04-28 | Дзе Скриппс Рисерч Инститьют | Композиции и способы жидкостной биопсии меланомы |
| WO2016033103A1 (en) * | 2014-08-25 | 2016-03-03 | Creatv Microtech, Inc. | Use of circulating cell biomarkers in the blood for detection and diagnosis of diseases and methods of isolating them |
| CN113552350B (zh) * | 2015-04-21 | 2024-10-11 | 基因泰克公司 | 用于前列腺癌分析的组合物和方法 |
| BR112018009071B1 (pt) * | 2015-11-06 | 2021-12-14 | Ventana Medical Systems, Inc | Método in vitro para preparar uma amostra representativa para análise |
| KR20170099787A (ko) * | 2016-02-23 | 2017-09-01 | 노을 주식회사 | 표지 물질을 저장하는 패치, 이를 이용하는 조직 진단 방법 및 장치 |
| US10371610B2 (en) | 2016-02-23 | 2019-08-06 | Noul Co., Ltd. | Contact-type patch, staining method using the same, and manufacturing method thereof |
| KR102478639B1 (ko) | 2016-02-23 | 2022-12-19 | 노을 주식회사 | 표지 물질을 저장하는 패치, 이를 이용하는 조직 진단 방법 및 장치 |
| KR20170099737A (ko) | 2016-02-23 | 2017-09-01 | 노을 주식회사 | 접촉식 염색 패치 및 이를 이용하는 염색 방법 |
| KR102406596B1 (ko) * | 2016-02-23 | 2022-06-10 | 노을 주식회사 | 패치를 이용하는 ctc 진단 방법 및 장치 |
| MX2019011769A (es) | 2017-04-03 | 2019-11-07 | Hoffmann La Roche | Anticuerpos que se unen a steap-1. |
| WO2019005902A1 (en) * | 2017-06-27 | 2019-01-03 | Qcdx, Llc | SYSTEM AND METHODS FOR DIAGNOSING QUANTITATIVE LIQUID BIOPSY |
| CN107918013A (zh) * | 2017-09-25 | 2018-04-17 | 浙江天科高新技术发展有限公司 | 化学发光酶免测定循环肿瘤细胞中K‑Ras蛋白的方法及试剂盒 |
| JP7678424B2 (ja) | 2018-05-10 | 2025-05-16 | 学校法人順天堂 | 画像解析方法、装置、コンピュータプログラム、及び深層学習アルゴリズムの生成方法 |
| US20220002429A1 (en) * | 2018-10-24 | 2022-01-06 | Northwestern University | Tumor cell aggregation inhibitors' for treating cancer |
| JP7381003B2 (ja) * | 2019-04-26 | 2023-11-15 | 学校法人順天堂 | 疾患解析を支援する方法、装置、及びコンピュータプログラム、並びにコンピュータアルゴリズムを訓練する方法、装置、及びプログラム |
| WO2023107566A1 (en) | 2021-12-07 | 2023-06-15 | Epic Sciences, Inc. | Enhanced characterization of breast cancer |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4391904A (en) | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein |
| EP0336562B1 (en) | 1988-03-04 | 1995-06-14 | Cancer Research Campaign Technology Ltd. | Improvements relating to antigens |
| US5869053A (en) | 1988-03-04 | 1999-02-09 | Cancer Research Campaign Technology, Ltd. | 5T4 antigen from human trophoblasts |
| WO1998055607A2 (en) | 1997-06-04 | 1998-12-10 | Oxford Biomedica (Uk) Limited | Tumor targeted vector |
| JP2003515323A (ja) | 1999-11-18 | 2003-05-07 | オックスフォード バイオメディカ（ユーケイ）リミテッド | 抗 体 |
| GB0126378D0 (en) | 2001-11-02 | 2002-01-02 | Oxford Biomedica Ltd | Antigen |
| US7305112B2 (en) | 2002-10-15 | 2007-12-04 | The Scripps Research Institute | Method of converting rare cell scanner image coordinates to microscope coordinates using reticle marks on a sample media |
| TW200616662A (en) * | 2004-09-10 | 2006-06-01 | Wyeth Corp | Humanized anti-5t4 antibodies and anti-5t4 antibody/calicheamicin conjugates |
| WO2007089911A2 (en) * | 2006-01-30 | 2007-08-09 | The Scripps Research Institute | Methods for detection of circulating tumor cells and methods of diagnosis of cancer in a mammalian subject |
| PL1994055T3 (pl) | 2006-03-10 | 2015-02-27 | Wyeth Llc | Przeciwciała anty-5T4 i ich zastosowanie |
| WO2008131048A2 (en) | 2007-04-16 | 2008-10-30 | Cellpoint Diagnotics, Inc. | Devices and methods for diagnosing, prognosing, or theranosing a condition by enriching rare cells |
| GB0822836D0 (en) * | 2008-12-15 | 2009-01-21 | Oxford Biomedica Ltd | Method |
| EP2995953B1 (en) | 2009-03-24 | 2017-11-29 | Biocept, Inc. | Devices and methods of cell capture and analysis |
| CA2754610C (en) | 2009-03-27 | 2015-05-05 | Marc Isaac Damelin | Tumor-initiating cells and methods for using same |
| US20120178094A1 (en) | 2009-09-03 | 2012-07-12 | Peter Kuhn | Method for Categorizing Circulating Tumor Cells |
| CA2778328C (en) | 2009-10-21 | 2018-12-18 | The Scripps Research Institute | Method of using non-rare cells to detect rare cells |
| US9469876B2 (en) * | 2010-04-06 | 2016-10-18 | Caris Life Sciences Switzerland Holdings Gmbh | Circulating biomarkers for metastatic prostate cancer |
| WO2012006421A2 (en) * | 2010-07-07 | 2012-01-12 | The Regents Of The University Of Michigan | Diagnosis and treatment of breast cancer |
| EP2694111B1 (en) | 2011-04-01 | 2016-08-10 | Wyeth LLC | Antibody-drug conjugates |
-
2013
- 2013-01-22 BR BR112014018192A patent/BR112014018192A8/pt not_active Application Discontinuation
- 2013-01-22 CA CA2861437A patent/CA2861437C/en not_active Expired - Fee Related
- 2013-01-22 IN IN7019DEN2014 patent/IN2014DN07019A/en unknown
- 2013-01-22 AU AU2013213301A patent/AU2013213301A1/en not_active Abandoned
- 2013-01-22 KR KR1020147020394A patent/KR101716555B1/ko not_active Expired - Fee Related
- 2013-01-22 WO PCT/IB2013/050547 patent/WO2013111054A1/en not_active Ceased
- 2013-01-22 ES ES13708526T patent/ES2724232T3/es active Active
- 2013-01-22 MX MX2014008928A patent/MX361058B/es active IP Right Grant
- 2013-01-22 RU RU2014127474A patent/RU2646498C2/ru active
- 2013-01-22 JP JP2014553836A patent/JP6254951B2/ja not_active Expired - Fee Related
- 2013-01-22 US US14/374,083 patent/US10254286B2/en not_active Expired - Fee Related
- 2013-01-22 CN CN201380006333.9A patent/CN104094116B/zh not_active Expired - Fee Related
- 2013-01-22 EP EP13708526.2A patent/EP2807485B1/en active Active
-
2014
- 2014-07-07 IL IL233543A patent/IL233543B/en active IP Right Grant
-
2018
- 2018-08-24 AU AU2018220154A patent/AU2018220154A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL233543A0 (en) | 2014-08-31 |
| US20150017661A1 (en) | 2015-01-15 |
| AU2018220154A1 (en) | 2018-09-13 |
| CA2861437A1 (en) | 2013-08-01 |
| CA2861437C (en) | 2018-08-21 |
| ES2724232T3 (es) | 2019-09-09 |
| RU2646498C2 (ru) | 2018-03-05 |
| US10254286B2 (en) | 2019-04-09 |
| WO2013111054A1 (en) | 2013-08-01 |
| JP2015507190A (ja) | 2015-03-05 |
| KR101716555B1 (ko) | 2017-03-14 |
| JP6254951B2 (ja) | 2017-12-27 |
| BR112014018192A8 (pt) | 2021-03-02 |
| EP2807485A1 (en) | 2014-12-03 |
| AU2013213301A1 (en) | 2014-07-17 |
| IN2014DN07019A (cg-RX-API-DMAC7.html) | 2015-04-10 |
| HK1202923A1 (en) | 2015-10-09 |
| MX2014008928A (es) | 2014-10-24 |
| KR20140100580A (ko) | 2014-08-14 |
| RU2014127474A (ru) | 2016-03-20 |
| CN104094116A (zh) | 2014-10-08 |
| EP2807485B1 (en) | 2019-03-13 |
| CN104094116B (zh) | 2017-05-31 |
| IL233543B (en) | 2018-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX361058B (es) | Método para detectar células tumorales circulantes 5t4-positivas y métodos de diagnóstico de cáncer 5t4-positivo en un sujeto mamífero. | |
| IL225646A0 (en) | Methods and kits for detecting cancer cells in the circulation of pancreatic patients using polyspecific capture and cocktail detection reagents | |
| WO2013138522A3 (en) | Methods for assessing effectiveness and monitoring oncolytic virus treatment | |
| AR095363A1 (es) | Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1 | |
| EA201390149A1 (ru) | Способы выявления заболевания или патологических состояний с использованием фагоцитарных клеток | |
| MX361731B (es) | Método para diagnosticar cáncer y kit de diagnóstico usando medición de actividad de células nk. | |
| WO2014028884A3 (en) | Cancer diagnostics using biomarkers | |
| JP2014144959A5 (cg-RX-API-DMAC7.html) | ||
| MX390772B (es) | Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias. | |
| HK1259001A1 (zh) | 癌症的预後和诊断方法 | |
| MX2016012697A (es) | Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales. | |
| EP2576833A4 (en) | METHOD AND DEVICE FOR THE POINT-OF-CARE DETECTION OF NUCLEIC ACID IN A SAMPLE | |
| HK1255533A1 (zh) | 用於检测大肠癌及进阶性腺瘤的蛋白质生物标志物面板 | |
| GB2519906A (en) | Methods and systems for detecting biological components | |
| MY188938A (en) | Therapeutic, diagnostic and prognostic methods for cancer of the bladder | |
| TN2013000358A1 (en) | Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects | |
| EP4060048A3 (en) | Non-invasive diagnostic method for diagnosing bladder cancer | |
| NZ629555A (en) | Monocyte biomarkers for cancer detection | |
| AR087363A1 (es) | Uso del anticuerpo i-3859 para la deteccion y diagnostico de los canceres | |
| PH12014502436A1 (en) | In vitro method for the diagnosis and surveillance of cancer | |
| WO2014028862A9 (en) | Use of dna in circulating exosomes as a diagnostic marker for metastasic disease | |
| EP3159695A3 (en) | Methods for diagnosing pancreatic cancer | |
| HK1258724A1 (zh) | 选择白血病对象的治疗方案的分析和方法 | |
| IN2014DN08537A (cg-RX-API-DMAC7.html) | ||
| EA201691682A1 (ru) | Способы анализирования редких циркулирующих в крови клеток |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |